Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 196 AL 210

Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease

Zheng BW, Yang L, Dai XL, Jiang ZF, Huang HC.

Neurol Res. 2016 Feb;38(2):177-86. doi: 10.1080/01616412.2015.1133485. Epub 2016 Mar 14.

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics

Rosini M, Simoni E, Caporaso R, Minarini A.

Future Med Chem. 2016 Apr;8(6):697-711. doi: 10.4155/fmc-2016-0003. Epub 2016 Apr 15.

Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll

Rego Â, Viana SD, Ribeiro CA, Rodrigues-Santos P, Pereira FC.

J Alzheimers Dis. 2016 Apr 12;52(4):1189-202. doi: 10.3233/JAD-151183.

Lost and found

Munoz-Lopez M, Morris RGM.

Neuroscience. 2016 Jun 21;326:v-vii. doi: 10.1016/j.neuroscience.2016.04.012. Epub 2016 Apr 13.

Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?

Pohanka M.

Curr Med Chem. 2016;23(14):1432-41. doi: 10.2174/0929867323666160418114733.

Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies

Ohno M.

Brain Res Bull. 2016 Sep;126(Pt 2):183-198. doi: 10.1016/j.brainresbull.2016.04.007. Epub 2016 Apr 16.

Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism

Hroudová J, Singh N, Fišar Z, Ghosh KK.

Eur J Med Chem. 2016 Oct 4;121:774-784. doi: 10.1016/j.ejmech.2016.03.084. Epub 2016 Mar 30.

CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease

Mendioroz M, Celarain N, Altuna M, Sánchez-Ruiz de Gordoa J, Zelaya MV, Roldán M, Rubio I, Larumbe R, Erro ME, Méndez I, Echávarri C.

Alzheimers Res Ther. 2016 Apr 19;8(1):15. doi: 10.1186/s13195-016-0183-0.

Targeting microglia for the treatment of Alzheimer's Disease

Wes PD, Sayed FA, Bard F, Gan L.

Glia. 2016 Oct;64(10):1710-32. doi: 10.1002/glia.22988. Epub 2016 Apr 21.

The Role of Insulin Resistance and Glucose Metabolism Dysregulation in the Development of Alzheimer´s Disease

Arrieta-Cruz I, Gutiérrez-Juárez R.

Rev Invest Clin. 2016 Mar-Apr;68(2):53-8.

EEG-directed connectivity from posterior brain regions is decreased in dementia with Lewy bodies: a comparison with Alzheimer's disease and controls

Dauwan M, van Dellen E, van Boxtel L, van Straaten ECW, de Waal H, Lemstra AW, Gouw AA, van der Flier WM, Scheltens P, Sommer IE, Stam CJ.

Neurobiol Aging. 2016 May;41:122-129. doi: 10.1016/j.neurobiolaging.2016.02.017. Epub 2016 Feb 21.

Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum

Serrano-Pozo A, Qian J, Muzikansky A, Monsell SE, Montine TJ, Frosch MP, Betensky RA, Hyman BT.

J Neuropathol Exp Neurol. 2016 Jun;75(6):516-26. doi: 10.1093/jnen/nlw026. Epub 2016 Apr 22.

Amyloid beta plaque: a culprit for neurodegeneration

Gupta A, Goyal R.

Acta Neurol Belg. 2016 Dec;116(4):445-450. doi: 10.1007/s13760-016-0639-9. Epub 2016 Apr 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias